Summary
RMC No. 58-2022 publishes the March 10, 2022 letter from the Food and Drug Administration endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act).
Key points
- Letter published. The letter is from FDA OIC-Director General Dr. Oscar G. Gutierrez, Jr.
- Updates to the List. The List corrects the names of certain medicines for hypertension and COVID-19 treatment.
Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.
Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.
